
0:00
8:42
Tam Maiuri, MaryAnn Emerick, and Allison Bartlett touch base on uniQure’s announcement that the FDA has accepted its application for AMT-130 and granted Priority Review, with a target action date of May 1, 2027. Join them for a brief conversation about this latest development for the Huntington’s disease community.
Don't forget to follow us on social media!
Flere episoder fra "The HDSA Podcast"



Gå ikke glip af nogen episoder af “The HDSA Podcast” - abonnér på podcasten med gratisapp GetPodcast.








